ARTICLE | Clinical News
Auryxia regulatory update
March 9, 2017 12:50 PM UTC
FDA accepted for review an sNDA from Keryx for Auryxia ferric citrate to treat iron deficiency anemia in patients with non-dialysis-dependent chronic kidney disease (CKD). The PDUFA date is Nov. 6. Th...